compounded semaglutide fda warning november 2025 🚨 Moves to Permanently Shut Down GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these New project announcement: HHS‑OIG is

retatrutide has no UK marketing authorisation, BNF listing, or NICE appraisal, and no guidelines exist for their combined use

GLP-1 Friendly Badges While the FDA primarily regulates foods and supplements, the US Department of Agriculture handles meat and poultry products about 20% of the food supply and require premarket approval of labels that make health claims such as GLP-1 Friendly. Food marketing claims targeting GLP-1 users have grown rapidly since 2024 as companies including Five companies have submitted 21 approval requests for labels describing meat or poultry-related foods as GLP-1 Friendly or for a GLP-1 Lifestyle, according to USDAs data as of June 2

Loved it

U.S.-based Eli Lilly also makes the current bestselling weight-loss drug, Zepbound, which is called Mounjaro when patients take it to fight diabetes

During recovery phase Continue all supportive measures until regrowth is well established

Whether these three work together hasnt been tested